Niagen Bioscience, Inc. (FRA:OCD1)
Germany · Delayed Price · Currency is EUR 3.960
-0.020 (-0.50%)
At close: Feb 20, 2026
-28.65% (1Y)
| Market Cap | 330.38M -21.0% |
| Revenue (ttm) | 106.29M +36.0% |
| Net Income | 17.41M +1,275.7% |
| EPS | 0.20 +1,093.8% |
| Shares Out | n/a |
| PE Ratio | 18.97 |
| Forward PE | 21.41 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 3 |
| Open | 3.960 |
| Previous Close | 3.980 |
| Day's Range | 3.960 - 3.960 |
| 52-Week Range | 3.960 - 12.400 |
| Beta | n/a |
| RSI | 32.75 |
| Earnings Date | Mar 4, 2026 |